During the past decade, Florida Cardiovascular Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Cardiovascular Institute" #1 sponsor was "CVRx, Inc." with 2 trials, followed by "Abbott" with 1 trials sponsored, "Anthera Pharmaceuticals" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Cardiovascular Institute" #1 collaborator was "Medtronic" with 1 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Florida Cardiovascular Institute" are "Heart Failure, Congestive" (2 trials), "Angioplasty" (1 trials), "Bradycardia" (1 trials), "Coronary Artery Disease" (1 trials) and "Coronary Artery Disease (CAD)" (1 trials). Many other conditions were trialed in "Florida Cardiovascular Institute" in a lesser frequency.

Most popular intervention types in "Florida Cardiovascular Institute" are "Drug" (5 trials), "Device" (3 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "A-002" (1 trials), "ARRY-371797 (PF-07265803)" (1 trials), "Atorvastatin" (1 trials) and "BMS-582949" (1 trials). Other intervention names were less common.

The vast majority of trials in "Florida Cardiovascular Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Florida Cardiovascular Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Florida Cardiovascular Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Cardiovascular Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".